Fenbendazole For Humans May Be Effective in Treating Cancer


Fenbendazole is a veterinary medication used to treat tapeworms, hookworms, roundworms, and whipworms in animals. It is commonly sold under brand names such as Panacur C and Safe-Guard. However, recently researchers have discovered that fenbendazole for humans may also be effective at decreasing cancer cells in addition to working alongside traditional cancer therapies.

According to Full Fact, a non-profit organization that strives to educate the public on issues of fake news and misinformation, Tippens’ claims have no evidence to support them. The medication hasn’t gone through clinical trials to prove it is safe or effective for treating human cancers. Moreover, it would be extremely difficult for the average person to acquire a prescription for fenbendazole because Health Canada lists it as a medication only approved for use in animals.

Despite the lack of evidence, the fenbendazole for cancer protocol has gained popularity on social media. The protocol involves taking the antiparasitic medication along with other supplements to reduce symptoms of cancer and supposedly promote healing. However, a number of studies have found that fenbendazole alone is not enough to kill cancerous cells and has the potential to harm healthy cells in the process.

The research was conducted by scientists from India and published in the journal Scientific Reports. Scientists treated human cancer cell lines with fenbendazole and found that it caused partial alteration of microtubules in the cell. In turn, this induced apoptosis in the cancerous cells and prevented their growth. In addition, fenbendazole was also able to inhibit glucose uptake in the cancerous cells.

In order to confirm the findings of their study, scientists also tested fenbendazole in mice with cancerous tumors. They fed them the drug for 12 days and observed a reduction in tumor size. They also performed a fluorescence based competitive binding assay and found that fenbendazole binds to tubulin at the colchicine binding site. This prevents the transport of glucose to cancer cells and blocks their growth.

Considering the results of their study, the scientists believe that fenbendazole could potentially be an effective cancer treatment. However, they caution that further studies are required in order to determine how fenbendazole interacts with other cancer treatments and whether it is capable of eliminating all types of cancerous cells.

Another similar medication, mebendazole, has been shown to be effective at killing cancer cells in laboratory experiments. Like fenbendazole, mebendazole prevents cancer cells from absorbing glucose, which is needed for them to grow. It has also been shown to cause apoptosis in the cells of some cancerous tissues.

Currently, the FDA and European Medicines Agency have not approved any anthelmintic medications for cancer treatment. Although many antiparasitic drugs have been shown to exhibit cancer-fighting properties, turning these findings into a viable treatment option is a long and complicated process. It will take years of testing to find out whether anthelmintic medications can actually cure cancer in humans. Until then, it’s best to stick with established cancer treatments like chemotherapy and radiation.  fenben for humans